Every earnings call for ENTERO — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ENTERO · 7 transcripts · Consumer Services · latest Q4 FY26Entero Healthcare Solutions Limited has 7 earnings calls on record here, a Consumer Services company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
FY26 Revenue (like-for-like) ₹6,591 cr (+32% YoY); FY26 EBITDA ₹266 cr; FY26 EBITDA Margin 4.0% (+1% YoY). Q4 FY26 EBITDA at INR86 crores, up 76% YoY, with margin at 4.5%.
Read full transcript & analysisRevenue ₹1,707 cr (+26% YoY); EBITDA ₹68 cr (+36% YoY); EBITDA Margin 4% (+0% YoY). Revenue grew 26% YoY to INR1,707 crores, with organic growth at 17.1%.
Read full transcript & analysisRevenue ₹1,571 cr (+21% YoY); EBITDA ₹62 cr (+46% YoY); EBITDA Margin 4.0% (+1% YoY). Revenue grew by 20.8% YoY to INR1,571 crores in Q2 FY26.
Read full transcript & analysisRevenue ₹1,404 cr (+28% YoY); EBITDA ₹50 cr (+66% YoY); EBITDA Margin 3.6%. Revenue grew 28% year-on-year to ₹1,404 crores, with like-to-like growth at 31%.
Read full transcript & analysisFY25 Revenue ₹5,096 cr (+30% YoY); FY25 EBITDA ₹172 cr (+53% YoY); FY25 EBITDA Margin 3.4%. FY25 Revenue crossed ₹5,000 crores, reaching ₹5,096 crores, a 30% YoY growth.
Read full transcript & analysisRevenue (Q2 FY25) ₹1,301 cr (+31% YoY); EBITDA (Q2 FY25) ₹42 cr (+49% YoY); EBITDA Margin (Q2 FY25) 3.3%. Consolidated revenue for Q2 FY25 stood at ₹1,301 crores, marking a robust 31% year-on-year increase.
Read full transcript & analysisRevenue ₹3,922 cr (+19% YoY); EBITDA ₹112 cr (+75% YoY); EBITDA Margin 2.9%. FY24 Total Operating Revenue reached INR 3,922 crores, marking a 19% YoY increase, significantly outpacing the pharmaceutical industry growth rate of 7.6%.
Read full transcript & analysis